148 related articles for article (PubMed ID: 34601710)
1. The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma.
Fodi C; Skardelly M; Hempel JM; Hoffmann E; Castaneda S; Tabatabai G; Honegger J; Tatagiba M; Schittenhelm J; Behling F
Neurosurg Rev; 2022 Aug; 45(4):2671-2679. PubMed ID: 34601710
[TBL] [Abstract][Full Text] [Related]
2. Differences in the expression of SSTR1-5 in meningiomas and its therapeutic potential.
Behling F; Fodi C; Skardelly M; Renovanz M; Castaneda S; Tabatabai G; Honegger J; Tatagiba M; Schittenhelm J
Neurosurg Rev; 2022 Feb; 45(1):467-478. PubMed ID: 33899156
[TBL] [Abstract][Full Text] [Related]
3. Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.
Silva CB; Ongaratti BR; Trott G; Haag T; Ferreira NP; Leães CG; Pereira-Lima JF; Oliveira Mda C
Int J Clin Exp Pathol; 2015; 8(10):13185-92. PubMed ID: 26722517
[TBL] [Abstract][Full Text] [Related]
4. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?
Barresi V; Alafaci C; Salpietro F; Tuccari G
Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896
[TBL] [Abstract][Full Text] [Related]
5. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T
J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781
[TBL] [Abstract][Full Text] [Related]
6. Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence.
Csonka T; Murnyák B; Szepesi R; Bencze J; Bognár L; Klekner A; Hortobágyi T
Folia Neuropathol; 2016; 54(2):114-26. PubMed ID: 27543769
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of the immunohistochemical expression of S100 in meningiomas.
Behling F; Fodi C; Skardelly M; Paulsen F; Tabatabai G; Honegger J; Tatagiba M; Schittenhelm J
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2975-2985. PubMed ID: 35838837
[TBL] [Abstract][Full Text] [Related]
8. The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?
Voß KM; Spille DC; Sauerland C; Suero Molina E; Brokinkel C; Paulus W; Stummer W; Holling M; Jeibmann A; Brokinkel B
J Neurooncol; 2017 Jul; 133(3):641-651. PubMed ID: 28527009
[TBL] [Abstract][Full Text] [Related]
9. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Approach to the Differential Diagnosis of Meningiomas and Their Mimics.
Boulagnon-Rombi C; Fleury C; Fichel C; Lefour S; Marchal Bressenot A; Gauchotte G
J Neuropathol Exp Neurol; 2017 Apr; 76(4):289-298. PubMed ID: 28340171
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy.
Hoffmann E; Clasen K; Frey B; Ehlers J; Behling F; Skardelly M; Bender B; Schittenhelm J; Reimold M; Tabatabai G; Zips D; Eckert F; Paulsen F
Radiat Oncol; 2021 Jun; 16(1):116. PubMed ID: 34172069
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome.
Bertero L; Dalla Dea G; Osella-Abate S; Botta C; Castellano I; Morra I; Pollo B; Calatozzolo C; Patriarca S; Mantovani C; Rudà R; Tardivo V; Zenga F; Garbossa D; Papotti M; Soffietti R; Ricardi U; Cassoni P
J Neuropathol Exp Neurol; 2019 Mar; 78(3):248-256. PubMed ID: 30689922
[TBL] [Abstract][Full Text] [Related]
13. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
Champeaux C; Dunn L
World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
[TBL] [Abstract][Full Text] [Related]
14. A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After Resection.
Chen WC; Vasudevan HN; Choudhury A; Pekmezci M; Lucas CG; Phillips J; Magill ST; Susko MS; Braunstein SE; Oberheim Bush NA; Boreta L; Nakamura JL; Villanueva-Meyer JE; Sneed PK; Perry A; McDermott MW; Solomon DA; Theodosopoulos PV; Raleigh DR
Neurosurgery; 2020 Dec; 88(1):202-210. PubMed ID: 32860417
[TBL] [Abstract][Full Text] [Related]
15. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.
Pessina F; Navarria P; Clerici E; Soffietti R; Nibali MC; Rudà R; Riva M; Scorsetti M; Bello L
World Neurosurg; 2019 Mar; 123():e273-e279. PubMed ID: 30496926
[TBL] [Abstract][Full Text] [Related]
16. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.
Cai Z; Zhang C; Zou Y; Lu C; Hu H; Qian J; Jiang L; Hu G
Int J Clin Oncol; 2017 Aug; 22(4):660-666. PubMed ID: 28243945
[TBL] [Abstract][Full Text] [Related]
17. AKT2 expression in histopathologic grading and recurrence of meningiomas.
Wang Q; Fan SY; Qian J; Wang JY; Lu YC; Hu GH; Luo C
Eur J Surg Oncol; 2014 Sep; 40(9):1056-61. PubMed ID: 24656454
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological analysis of receptor tyrosine kinases in meningiomas: the expression of VEGFR-2 in meningioma was associated with a higher WHO grade and shorter progression-free survival.
Nakada S; Sasagawa Y; Tachibana O; Iizuka H; Kurose N; Shioya A; Guo X; Yamada S; Nojima T
Brain Tumor Pathol; 2019 Jan; 36(1):7-13. PubMed ID: 30519894
[TBL] [Abstract][Full Text] [Related]
19. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
20. Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors.
Kaemmerer D; Peter L; Lupp A; Schulz S; Sänger J; Baum RP; Prasad V; Hommann M
Int J Clin Exp Pathol; 2012; 5(3):187-94. PubMed ID: 22558472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
